| 6QHB: reference: Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome., White GV, Edgar EV, Holmes DS, Lewell XQ, Liddle J, Polyakova O, Smith KJ, Thorpe JH, Walker AL, Wang Y, Young RJ, Hovnanian A, Bioorg Med Chem Lett. 2019 Mar 15;29(6):821-825. doi: 10.1016/j.bmcl.2019.01.020., Epub 2019 Jan 22. PMID: 30691925 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).